What Hanseler does

Hänseler AG is a privately held Swiss pharmaceutical production and trading company headquartered in Herisau, Switzerland, founded in 1964 and majority-owned by the Steinegg Stiftung. The company operates three integrated business lines: (1) pharmaceutical raw materials trading with a portfolio of more than 3,000 SKUs including essential oils, chemicals, extracts, tinctures, herbs, vitamins, and acids; (2) manufacturing and distribution of OTC preparations under proprietary brands (Gly-Coramin, Kelosoft, Mavena, Hänseler D-Mannose, Hänseler Menopause) and licensed brands (Original Bach/RESCUE, OLBAS, Bronchostop, Probactiol); and (3) CDMO (Contract Development and Manufacturing Organization) services spanning product development, sourcing, manufacturing, and packaging of liquid, semi-solid, and solid dosage forms under GMP standards with 12,000-liter liquid tanks and 500 tonnes of annual production capacity.

The company is GMP, GDP, and Swissmedic certified, bio.inspecta certified for organic products, holds a narcotics handling license, and successfully passed an FDA audit in 2022. Distribution reaches nearly all of Switzerland's approximately 1,800 pharmacies and 400 drugstores via a regional outside sales force, plus major retail chains (Migros, Coop) for consumer brands. B2B customers include industrial CDMO partners in pharmaceutical, cosmetics, and food industries served through dedicated key account managers, and international/export customers sourcing raw materials. Exclusive Swiss distribution partnerships exist with Frey+Lau (essential oils), Klenk (natural ingredients), and IOI Oleo (oleochemicals).

Hänseler generates revenue through three primary streams: OTC product sales via pharmacy and drugstore channels, raw material trading with both branded and in-house manufactured products, and CDMO contract manufacturing services. B2B online shop access requires verified business customer status with minimum order thresholds. The company's growth posture is signaled by the April 2026 inauguration of a new GMP production building, expansion to two-shift operations in February 2024, and incremental international market entries including THMP approvals in Spain, Norway, and Sweden and operations in Germany and China.

Name

Hanseler

Legal name

Hänseler AG

Website

https://haenseler.ch

Company type

Private

Founded year

1964

Operating status

Operating

Headcount range

51–100 employees

Short description

Hänseler AG is a Swiss GMP-certified pharmaceutical company operating three integrated lines: pharmaceutical raw materials trading (3,000+ SKUs), OTC brand manufacturing and distribution, and CDMO services in liquid, semi-solid, and solid dosage forms serving Swiss pharmacies, drugstores, and industrial partners.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

akta.pro primary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

akta.pro secondary industries

Small-Molecule API & Intermediates CDMO (HLAGABAA), Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB), Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ), Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

Keywords

• Pharmaceutical contract manufacturing
• OTC pharmaceutical products
• Pharmaceutical raw materials
• GMP-certified manufacturing
• CDMO services

Headquarters

HQ city

Herisau

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. OTC Pharmaceutical Product Sales: Sale of proprietary OTC preparations including Gly-Coramin, Bach Flower Remedies/RESCUE, OLBAS, Kelosoft, Mavena, Bronchostop, Probactiol, and others through Swiss pharmacies and drugstores. Revenue from finished dosage form products sold under company-owned and licensed brands.
2. Pharmaceutical Raw Material Trading: Trading and further processing of over 3,000 pharmaceutical raw materials including essential oils, chemicals, extracts, tinctures, herbs, vitamins, salts, and acids. Materials sold as registered brand products or manufactured in-house. Serves Swiss pharmacies, drugstores, and industrial/export customers.
3. CDMO Contract Manufacturing: Contract development and manufacturing services for partner firms in pharmaceutical, cosmetics, and food industries. Services span from product development and raw material sourcing through manufacturing, packaging, and market access support. Includes exclusive trading access and toll manufacturing capabilities.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Hänseler AG is a Swiss GMP-certified pharmaceutical CDMO that develops, sources, manufactures, and packages liquid, semi-solid, and solid dosage forms for industrial partners. The company also produces and distributes its own OTC preparations under proprietary and licensed brands and trades more than 3,000 pharmaceutical raw materials to pharmacies, drugstores, and industrial/export customers.

Product overview

Hänseler AG is a Swiss pharmaceutical company offering OTC preparations and CDMO services. The product portfolio encompasses medicines, medical devices, food supplements, and cosmetics, with key brands including Gly-Coramin® (energy), RESCUE® (Bach® flower essences for emotional wellness), OLBAS® and Bronchostop® (respiratory), Hänseler D-Mannose and Nieren- und Blasendragées S (urinary tract), Mavena B12 (dermatological), Probactiol® (probiotics), and Kelosoft® (acquired scar treatment brand). The company operates as both a product manufacturer/distributor and a CDMO (Contract Development and Manufacturing Organization) providing development, sourcing, manufacturing, packaging, and market access services for liquid, semi-solid, and solid dosage forms. Raw materials include over 3,000 pharmaceutical-grade substances. The CDMO services are organized into Liquid Solutions, Semi-Solid Solutions, and Solid Solutions, supported by documentation packages for regulatory compliance.

Differentiator

Problem solved

Functional benefit

Brands

• RESCUE: Bach flower emergency remedy product line for emotional balance and well-being
• Gly-Coramin
• OLBAS
• Kelosoft
• Alcacyl
• Mavena
• Bronchostop
• Probactiol
• Nieren- und Blasendragées S
• Planox
• Liquid Solutions
• Semi-Solid Solutions
• Solid Solutions

Products and services

• CDMO Services Full-service pharmaceutical contract development and manufacturing including product development, raw material sourcing, GMP manufacturing, packaging, regulatory documentation, and Swiss market access support for pharmaceutical, cosmetics, and food industry partners.
• Pharmaceutical Raw Materials Catalog of more than 3,000 pharmaceutical-grade raw materials including essential oils, extracts, tinctures, herbs, vitamins, salts, acids, chemicals, and excipients supplied to pharmacies, drugstores, and industrial customers with full regulatory documentation.
• RESCUE Product Line Bach flower essence product line including Original Bach Blüten 1-38 and RESCUE emergency drops for emotional wellness and stress relief, distributed in Swiss specialist retail.
• Gly-Coramin Brand Energy and circulation stimulant product including Gly-Coramin tablets for fatigue and altitude discomfort and Gly-Cora Boost caffeine toffee for on-demand energy, sold through Swiss pharmacies and drugstores.
• Olbas Essential-oil-based herbal medicine for cold symptoms including rhinitis, sore throat, and cough, sold through Swiss pharmacies and drugstores.
• Bronchostop Product Line Herbal cough remedy range including Bronchostop DUO lozenges, DUO syrup, and Bronchostop Junior products for adults and children.
• Kelosoft Topical scar therapy cream containing green oil from henbane for scar treatment and skin care.
• Mavena Product Line Dermatological product range with vitamin B12 for dry, itchy, and flaky skin including gel, cream, lotion, shampoo, and intensive care formulations.
• Probactiol Product Line Probiotic supplement range including Probactiol 10 Plus and Probactiol 25 with live bacterial cultures for digestive health.
• Hänseler D-Mannose Product Family D-Mannose based product family including Direct, Nature, Plus, and Gel variants for urinary tract support and intimate area care.
• Nieren- und Blasendragées S Herbal medicine for irritation of the urinary tract sold in Swiss pharmacies and exported to Norway.
• Tea Drugs / Medicinal Plants GMP-certified assortment of medicinal plants and tea drugs for pharmaceutical tea manufacturing, compliant with Swissmedic and European Pharmacopoeia standards.

Quantifiable outcome

• Nearly all of Switzerland's 1,800 pharmacies and 400 drugstores are Hänseler customers
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• Frey+LaucoreChannel Partner/ Reseller/ DistributorFrey+Lau is represented by Hänseler AG exclusively in Switzerland for essential oils. Hänseler distributes Frey+Lau's full range including pharmaceutical quality essential oils, excipient-grade oils, bio/organic certified oils, and aroma chemicals to the Swiss market. Product lists available for download including Wirkstoffe (active substances), Hilfsstoffe (excipients), and Bio quality.
• KlenkcoreChannel Partner/ Reseller/ DistributorKlenk is represented by Hänseler AG exclusively in Switzerland as a natural ingredients supplier. Klenk specializes in natural raw materials and botanical ingredients for pharmaceutical, cosmetic, and food applications.
• IOI Oleo GmbHcoreChannel Partner/ Reseller/ DistributorIOI Oleo GmbH is represented by Hänseler AG exclusively in Switzerland for oleochemical products. IOI Oleo supplies specialty oleochemicals used in pharmaceutical, cosmetic, and food industry applications.

Scale indicators10 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Siegfried Holding AG: Swiss-listed CDMO with API and finished dosage form manufacturing for small molecules. Directly comparable to Hänseler as a Swiss-headquartered CDMO offering integrated drug substance and drug product services, although at substantially larger scale.
• Dottikon Exclusive Synthesis AG: Swiss specialty CDMO focused on hazardous chemistry and APIs/intermediates. Comparable to Hänseler's intermediates trading (GID) and small-molecule manufacturing focus, with similar Swiss regulatory pedigree.
• Weleda AG: Swiss manufacturer of natural pharmaceuticals, anthroposophic medicines, and natural cosmetics with in-house production and proprietary brands. Comparable to Hänseler's herbal/plant-based OTC and natural raw material business, and similarly Swiss-rooted.
• Spirig HealthCare AG: Swiss OTC and dermo-cosmetic manufacturer with strong Swiss pharmacy channel presence. Comparable to Hänseler's OTC and dermatology brands (e.g., Mavena) and distribution model through Swiss specialist retail.

Broad incumbents

• Lonza Group AG: Swiss-headquartered global CDMO leader across small molecules, biologics, and cell/gene therapy. Overlaps with Hänseler on small-molecule and integrated CDMO services but operates at vastly greater scale and breadth.
• Catalent, Inc. Large global CDMO with deep capabilities in oral solid, sterile fill-finish, and softgel dosage forms. Competes with Hänseler for small-molecule drug product CDMO mandates, but at much larger scale and geographic footprint.

Emerging players

• Aenova Group GmbH: European CDMO with solid, semi-solid, and liquid dosage form capabilities serving pharma and consumer health. Comparable mid-market competitor to Hänseler for small-to-mid sized CDMO contracts.
• Recipharm AB: European CDMO with broad small-molecule drug product capabilities across multiple sites. Comparable as a peer in the European CDMO market that Hänseler competes in for contract manufacturing customers.

Regional players

• Doetsch Grether AG: Swiss distributor and brand owner in pharmacy and drugstore channels. Comparable to Hänseler's OTC distribution muscle and Swiss retail relationships, although focused on distribution rather than in-house manufacturing.
• Galexis AG: Leading Swiss pharmaceutical wholesaler and logistics provider. Comparable as a Swiss pharma supply chain counterpart that influences the distribution economics Hänseler faces when serving the same pharmacy and drugstore network.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@haenselerag
• Facebookfacebook.com/HaenselerSwissPharma
• Instagraminstagram.com/haenseler_swiss_pharma
• Xx.com/grippometer
• LinkedInlinkedin.com/company/h-nseler-ag

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hanseler